Rituximab BS IV infusion 500mg “Pfizer” is a biosimilar of rituximab (genetical recombination), manufactured by Pfizer. This injectable drug (YJ code: 4291451A2024) is supplied as 500mg in 50mL per bottle, used to treat non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and other autoimmune diseases.
Rituximab BS IV infusion 500mg “Pfizer”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →